Race, insurance status, and desire for tubal sterilization reversal
To access this article, please choose from the options below
Dr. Creinin is a consultant and advisor for Organon; is on the speaker's bureau for Berlex and Organon; and has received research grants from Organon, Galen, and Berlex.
PII: S0015-0282(07)01385-4
doi:10.1016/j.fertnstert.2007.06.041
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

